Class Effect for Sodium Glucose-Cotransporter-2 Inhibitors in Cardiovascular Outcomes: Implications for the Cardiovascular Disease Specialist.

Bethel, M Angelyn;McMurray, John J V;

Circulation 2018 Vol. 137 pp. 1218-1220

46

bethel2018classcirculation

diabetes mellitus mortality empagliflozin myocardial infarction cardiovascular diseases canagliflozin sglt-2 inhibitor

DOI:

ID: 279216

Ref Key: bethel2018classcirculation

Use this key to autocite in SciMatic or Thesis Manager

No Bibliography

Account:

NFT Contract Address:

0x95644003c57E6F55A65596E3D9Eac6813e3566dA

Article ID:

279216

Unique Identifier:

10.1161/CIRCULATIONAHA.117.030117

Network:

Scimatic Chain (ID: 481)

Authors

Abstract

Journal Name

Year

Title

4/5

Blockchain Upload Locked

Complete all 5 checklist items to tokenize your article

Gas fees required in SCI Coins

Coming soon

Reference Key: lastname+year+titlefirstword+journalfirstword

Article Type (Article, Book, Proceedings etc.)

Add a reference in a raw form. Our automatic system will correct it later.